Open access
Aug 2026
Hepatocellular carcinoma organoids enable drug discovery and combination therapy across heterogeneous tumors.
A biobank of patient-derived HCC organoids generated from diagnostic biopsies is established, establishing patient-derived organoids as a scalable platform for functional drug discovery and support combination strategies improving response across heterogeneous HCC.
S. Nuciforo, L. Blukacz, Marie-Anne Heusler et al.
· Cell Reports · 0 citations